Lianxin Hu

5PUBLICATIONS
22CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 23, 2026
SPOP-mediated ZMYND8 ubiquitination and phase separation exclusion drives mTOR inhibitor resistance in kidney cancer.

|May 02, 2024
Von Hippel-Lindau protein signalling in clear cell renal cell carcinoma.

Chengheng Liao, Lianxin Hu, Qing Zhang

|Nov 08, 2022
Histone H3 proline 16 hydroxylation regulates mammalian gene expression.

Xijuan Liu, Jun Wang, Joshua A Boyer

|Jul 22, 2020
Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer.

Chengheng Liao, Yang Zhang, Cheng Fan

|May 29, 2020
USP37 promotes deubiquitination of HIF2α in kidney cancer.

Kai Hong, Lianxin Hu, Xijuan Liu

Pageof 1

Frequent Collaborators

5 joint publications

Yang Zhang

4 joint publications

Chengheng Liao

2 joint publications

Jeremy M Simon

1 joint publications

Xingnan Zheng